Hundred-fold increase in SARS-CoV-2 spike antibody levels over three years in a hospital clinical laboratory
Description
Natural infection with the SARS-CoV-2 virus and vaccination increase the serum spike antibody levels. These levels, which differ among the various commercial assays, are used by the FDA to qualify individuals as potential COVID-19 convalescent plasma
